Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of an AAV-1 Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

NCT07346144 is registered in ClinicalTrials.gov with Trogenix ltd as lead sponsor.

NCT NCT07346144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07346144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of an AAV-1 Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
Lead sponsor
Trogenix ltd
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 21, 2026
Completion date
September 30, 2033
Enrollment
68 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma (gbm), high grade gliomas, newly diagnosed glioblastoma, recurrent glioblastoma